InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: WeeZuhl post# 149157

Saturday, 03/28/2015 9:00:18 AM

Saturday, March 28, 2015 9:00:18 AM

Post# of 405135
WeeZuhl The short answer is no because Naltrexone in Contrave is the API Naltrexone and not the ANDA or the NDA.

Will ELTP Generic Naltrexone Generate Bariatric Revenue?



Same answer as $ELTP's ADTs will not be helped by $ELTP's approved ANDA with all of its excipients whereas the Naltrexone in $ELTP's ADTs is the pure API Naltrexone. The same case as for Orexigen/Takeda's Contrave.

Hopefully that helps.

I want to thank you for all of your excellent DD and taking the time to add your Doctor MD experience to this MB. It is very much appreciated.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News